GR3030733T3 - Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them - Google Patents

Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them

Info

Publication number
GR3030733T3
GR3030733T3 GR990401812T GR990401812T GR3030733T3 GR 3030733 T3 GR3030733 T3 GR 3030733T3 GR 990401812 T GR990401812 T GR 990401812T GR 990401812 T GR990401812 T GR 990401812T GR 3030733 T3 GR3030733 T3 GR 3030733T3
Authority
GR
Greece
Prior art keywords
derivatives
sulphamate
producing
methods
compounds containing
Prior art date
Application number
GR990401812T
Other languages
English (en)
Inventor
Sigfrid Schwarz
Walter Elger
Gudrun Reddersen
Birgitt Schneider
Ina Thieme
Margit Richter
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of GR3030733T3 publication Critical patent/GR3030733T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR990401812T 1995-10-19 1999-07-09 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them GR3030733T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19540233A DE19540233B4 (de) 1995-10-19 1995-10-19 Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PCT/DE1996/001823 WO1997014712A2 (de) 1995-10-19 1996-09-19 Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
GR3030733T3 true GR3030733T3 (en) 1999-11-30

Family

ID=7776061

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990401812T GR3030733T3 (en) 1995-10-19 1999-07-09 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them

Country Status (13)

Country Link
EP (1) EP0862577B1 (el)
JP (2) JPH11505268A (el)
KR (1) KR100306044B1 (el)
CN (1) CN1125077C (el)
AT (1) ATE178903T1 (el)
AU (1) AU1436097A (el)
BR (1) BR9610905A (el)
DE (2) DE19540233B4 (el)
DK (1) DK0862577T3 (el)
ES (1) ES2131972T3 (el)
GR (1) GR3030733T3 (el)
RU (1) RU2159774C2 (el)
WO (1) WO1997014712A2 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064013A1 (en) * 1998-06-10 1999-12-16 Sterix Limited Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase
DE19712488A1 (de) 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
DE19943708B4 (de) * 1999-09-08 2007-12-20 Bayer Schering Pharma Ag Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
EP1769799A3 (en) * 2000-01-14 2010-01-13 Sterix Limited Pharmaceutical compositions containing steroidal structures and uses thereof
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE10139494A1 (de) * 2001-08-13 2003-03-06 Jenapharm Gmbh Antitumor wirksame 2-Alkoxyestradiolsulfamate
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
DE10307104A1 (de) * 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
US20080292765A1 (en) * 2007-05-22 2008-11-27 The Coca-Cola Company Sweetness Enhancers, Sweetness Enhanced Sweetener Compositions, Methods for Their Formulation, and Uses
GB201302368D0 (en) * 2013-02-11 2013-03-27 Univ Bath Compound
RU2562242C1 (ru) * 2014-07-10 2015-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный университет" (СПбГУ) РАЦЕМИЧЕСКИЙ 2,17β-ДИСУЛЬФАМОИЛОКСИ-3-МЕТОКСИ-8α-ЭСТРА-1,3,5(10)-ТРИЕН В КАЧЕСТВЕ ИНГИБИТОРА ПРОЛИФЕРАЦИИ ОПУХОЛЕВЫХ КЛЕТОК MCF-7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2133484A2 (en) * 1969-04-29 1972-12-01 Jenapharm Veb 3-17 and 21-sulphonyloxy-steroids - with androgenic anabolic progestogenic and oestrogen activity of long duration
IL94183A (en) * 1989-05-05 2003-09-17 Baylor College Medicine cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
EP0429628B1 (en) * 1989-06-16 1998-09-02 Genencor International, Inc. Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin

Also Published As

Publication number Publication date
ES2131972T3 (es) 1999-08-01
EP0862577A2 (de) 1998-09-09
EP0862577B1 (de) 1999-04-14
DE19540233A1 (de) 1997-04-24
JPH11505268A (ja) 1999-05-18
JP3040175B2 (ja) 2000-05-08
RU2159774C2 (ru) 2000-11-27
ATE178903T1 (de) 1999-04-15
CN1200126A (zh) 1998-11-25
BR9610905A (pt) 1999-07-13
KR19990064144A (ko) 1999-07-26
DE59601683D1 (de) 1999-05-20
WO1997014712A2 (de) 1997-04-24
DK0862577T3 (da) 1999-10-25
AU1436097A (en) 1997-05-07
CN1125077C (zh) 2003-10-22
DE19540233B4 (de) 2005-08-25
KR100306044B1 (ko) 2001-12-05
WO1997014712A3 (de) 1997-06-05

Similar Documents

Publication Publication Date Title
GR3030733T3 (en) Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MD1838F2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
MX9702932A (es) L-ribofuranosilnucleosidos.
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
GR3000287T3 (en) Taxol derivatives, their preparation and pharmaceutical compositions containing them
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
IL112622A (en) Iminoalkylamino or aminoalkylideneamino camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
FR2689127B1 (fr) Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
MY115211A (en) Novel amino acid derivatives, their preparation and use
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
NZ332834A (en) Glycosaminoglycan-related carbohydrate derivatives ( 5 saccharide groups ) having 4 to 6 sulphate groups
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
DE69022845D1 (en) Erythromycinderivate.
UA41871C2 (uk) Похідні еритроміцину, спосіб їх одержання та фармацевтична композиція на їх основі
BG101722A (en) New cumarine derivatives, methods for their preparation and application
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
HUT58065A (en) Process for producing new 4'-epi-4'-aminoanthracyclines and pharmaceutical composiktions comprising same
GR80173B (en) Spiro (benzofuran-azalkanes), method for their preparation and their use as medicaments
BG101163A (en) 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them
ES2000614A6 (es) Procedimiento de obtencion de nuevos complejos de platino (ii) derivados del 2,3-dimercapto-2-butene-dinitrilato (2-)-s,s'"
HUT57746A (en) Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same
HUP9802072A2 (hu) Benzo-tiopiráno-indazol-származékok és az ezeket tartalmazó gyógyszerkészítmények